Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

作者：Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J. Legat, Kim Papp, Linda Stein Gold, Jean‐David Bouaziz, Andrew Pink, J.M. Carrascosa, Barbara Rewerska, Jacek C. Szepietowski, Dorota Krasowska, Blanka Havlíčková, Monika Kalowska, Nina Magnolo, Sylvia Pauser, Navid Nami, Maxwell Sauder, Vipul Jain, Kamila Padlewska, Soo Yeon Cheong, Patricia Fleuranceau Morel, Liliana Ulianov, Christophe Piketty · 发表于：The Lancet · 年份：2024 · DOI：10.1016/s0140-6736(24)01203-0 · 被引用次数：144 · 研究领域：Dermatology and Skin Diseases、Psoriasis: Treatment and Pathogenesis、Asthma and respiratory diseases